Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.
作者信息
Scott E M, Gaywood I, Scott B B
机构信息
Department of Endocrinology, St James's University Hospital, Leeds, UK.
出版信息
Gut. 2000 Jan;46 Suppl 1(Suppl 1):i1-8. doi: 10.1136/gut.46.suppl_1.i1.
Abstract
摘要
相似文献
1
Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.
Gut. 2000 Jan;46 Suppl 1(Suppl 1):i1-8. doi: 10.1136/gut.46.suppl_1.i1.
2
A strategy for osteoporosis in gastroenterology.
Eur J Gastroenterol Hepatol. 1998 Aug;10(8):689-96; discussion 696-8.
3
Prevention and treatment of osteoporosis in patients with inflammatory bowel disease.
Am J Gastroenterol. 1999 Apr;94(4):878-83. doi: 10.1111/j.1572-0241.1999.981_d.x.
4
[When and how should osteoporosis be treated?].
Duodecim. 1993;109(20):1785-92.
5
Letter: abnormal bone densitometry in patients with coeliac disease -beyond malabsorption and sunlight exposure.
Aliment Pharmacol Ther. 2016 Mar;43(5):658-9. doi: 10.1111/apt.13512.
6
Management of osteoporosis in patients with gastrointestinal diseases.
Eur J Gastroenterol Hepatol. 2003 Aug;15(8):869-76. doi: 10.1097/00042737-200308000-00006.
7
Osteoporosis and upper extremity fragility fractures.
J Hand Surg Am. 2012 Jan;37(1):165-7. doi: 10.1016/j.jhsa.2011.09.025. Epub 2011 Oct 28.
8
Prevention and treatment of osteoporosis in inflammatory bowel disease.
Inflamm Bowel Dis. 2006 Aug;12(8):797-813. doi: 10.1097/00054725-200608000-00016.
9
Time to end steroid-induced fractures.
Arch Dermatol. 2001 Apr;137(4):493-4.
10
Steroid-induced osteoporosis.
Osteoporos Int. 1997;7 Suppl 3:S213-6. doi: 10.1007/BF03194375.
引用本文的文献
1
Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease.
Intest Res. 2025 Jul;23(3):254-289. doi: 10.5217/ir.2024.00185. Epub 2025 Apr 29.
2
Comparing Stacking Ensemble Techniques to Improve Musculoskeletal Fracture Image Classification.
J Imaging. 2021 Jun 21;7(6):100. doi: 10.3390/jimaging7060100.
3
Vitamin D Deficiency in Chronic Childhood Disorders: Importance of Screening and Prevention.
Nutrients. 2023 Jun 19;15(12):2805. doi: 10.3390/nu15122805.
4
Osteoporosis and Celiac Disease: Updates and Hidden Pitfalls.
Nutrients. 2023 Feb 22;15(5):1089. doi: 10.3390/nu15051089.
5
Intensity-specific considerations for exercise for patients with inflammatory bowel disease.
Gastroenterol Rep (Oxf). 2023 Feb 20;11:goad004. doi: 10.1093/gastro/goad004. eCollection 2023.
6
The Effect of a Gluten-Free Diet on Vitamin D Metabolism in Celiac Disease: The State of the Art.
Metabolites. 2023 Jan 2;13(1):74. doi: 10.3390/metabo13010074.
7
Both indirect maternal and direct fetal genetic effects reflect the observational relationship between higher birth weight and lower adult bone mass.
BMC Med. 2022 Oct 4;20(1):361. doi: 10.1186/s12916-022-02531-w.
8
Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease.
Gastroenterol Res Pract. 2022 Apr 4;2022:1498293. doi: 10.1155/2022/1498293. eCollection 2022.
9
Nutrient, Fibre, and FODMAP Intakes and Food-related Quality of Life in Patients with Inflammatory Bowel Disease, and Their Relationship with Gastrointestinal Symptoms of Differing Aetiologies.
J Crohns Colitis. 2021 Dec 18;15(12):2041-2053. doi: 10.1093/ecco-jcc/jjab116.
10
Prevalence and Risk Factors for Osteopathy in Chronic Pancreatitis.
Dig Dis Sci. 2021 Nov;66(11):4008-4016. doi: 10.1007/s10620-020-06732-2. Epub 2021 Jan 12.
本文引用的文献
1
A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update.
J Intern Med. 1998 Oct;244(4):271-92. doi: 10.1046/j.1365-2796.1998.00408.x.
2
A strategy for osteoporosis in gastroenterology.
Eur J Gastroenterol Hepatol. 1998 Aug;10(8):689-96; discussion 696-8.
3
Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.
N Engl J Med. 1997 Sep 4;337(10):670-6. doi: 10.1056/NEJM199709043371003.
4
Vitamin D supplementation: a word of caution.
Ann Intern Med. 1997 Aug 1;127(3):231-3. doi: 10.7326/0003-4819-127-3-199708010-00009.
5
Preventing glucocorticoid-induced osteoporosis.
N Engl J Med. 1997 Aug 7;337(6):420-1. doi: 10.1056/NEJM199708073370609.
6
Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.
N Engl J Med. 1997 Aug 7;337(6):382-7. doi: 10.1056/NEJM199708073370603.
7
Postmenopausal hormone therapy and mortality.
N Engl J Med. 1997 Jun 19;336(25):1769-75. doi: 10.1056/NEJM199706193362501.
8
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study.
Gut. 1997 Mar;40(3):313-9. doi: 10.1136/gut.40.3.313.
9
Reduced bone density in patients with inflammatory bowel disease.
Gut. 1997 Feb;40(2):228-33. doi: 10.1136/gut.40.2.228.
10
Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med. 1996 Dec 15;125(12):961-8. doi: 10.7326/0003-4819-125-12-199612150-00004.
Zotero 插件